Dehydroepiandrosterone Activation of G-protein-coupled Estrogen Receptor Rapidly Stimulates MicroRNA-21 Transcription in Human Hepatocellular Carcinoma Cells*

Background: MicroRNA-21 (miR-21) is an oncomiR in human hepatocellular carcinoma and is highly expressed in liver, but its regulation is uncharacterized. Results: Dehydroepiandrosterone (DHEA) rapidly increases miR-21 transcription in HepG2 cells by activating G-protein-coupled estrogen receptor (GPER). Conclusion: miR-21 transcription is regulated by DHEA through GPER. Significance: GPER may be among the activators of miR-21 expression in human hepatocellular carcinoma. Little is known about the regulation of the oncomiR miR-21 in liver. Dehydroepiandrosterone (DHEA) regulates gene expression as a ligand for a G-protein-coupled receptor and as a precursor for steroids that activate nuclear receptor signaling. We report that 10 nm DHEA increases primary miR-21 (pri-miR-21) transcription and mature miR-21 expression in HepG2 cells in a biphasic manner with an initial peak at 1 h followed by a second, sustained response from 3–12 h. DHEA also increased miR-21 in primary human hepatocytes and Hep3B cells. siRNA, antibody, and inhibitor studies suggest that the rapid DHEA-mediated increase in miR-21 involves a G-protein-coupled estrogen receptor (GPER/GPR30), estrogen receptor α-36 (ERα36), epidermal growth factor receptor-dependent, pertussis toxin-sensitive pathway requiring activation of c-Src, ERK1/2, and PI3K. GPER antagonist G-15 attenuated DHEA- and BSA-conjugated DHEA-stimulated pri-miR-21 transcription. Like DHEA, GPER agonists G-1 and fulvestrant increased pri-miR-21 in a GPER- and ERα36-dependent manner. DHEA, like G-1, increased GPER and ERα36 mRNA and protein levels. DHEA increased ERK1/2 and c-Src phosphorylation in a GPER-responsive manner. DHEA increased c-Jun, but not c-Fos, protein expression after 2 h. DHEA increased androgen receptor, c-Fos, and c-Jun recruitment to the miR-21 promoter. These results suggest that physiological concentrations of DHEA activate a GPER intracellular signaling cascade that increases pri-miR-21 transcription mediated at least in part by AP-1 and androgen receptor miR-21 promoter interaction.

[1]  Xiuping Liu,et al.  Regulation of the Extrinsic Apoptotic Pathway by MicroRNA-21 in Alcoholic Liver Injury* , 2014, The Journal of Biological Chemistry.

[2]  C. Klinge,et al.  Dehydroepiandrosterone-induces miR-21 transcription in HepG2 cells through estrogen receptor β and androgen receptor , 2014, Molecular and Cellular Endocrinology.

[3]  Jie Shen,et al.  Decrease expression of microRNA-744 promotes cell proliferation by targeting c-Myc in human hepatocellular carcinoma , 2014, Cancer Cell International.

[4]  E. Prossnitz,et al.  Estrogen biology: New insights into GPER function and clinical opportunities , 2014, Molecular and Cellular Endocrinology.

[5]  P. Pontisso,et al.  MicroRNAs and SerpinB3 in hepatocellular carcinoma. , 2014, Life sciences.

[6]  Xintian Zhang,et al.  ER-α36-Mediated Rapid Estrogen Signaling Positively Regulates ER-Positive Breast Cancer Stem/Progenitor Cells , 2014, PloS one.

[7]  J. Gustafsson,et al.  Insight into the mechanisms of action of estrogen receptor β in the breast, prostate, colon, and CNS. , 2013, Journal of molecular endocrinology.

[8]  G. Reynolds,et al.  Loss of 5α-Reductase Type 1 Accelerates the Development of Hepatic Steatosis but Protects Against Hepatocellular Carcinoma in Male Mice , 2013, Endocrinology.

[9]  N. Samaras,et al.  A review of age-related dehydroepiandrosterone decline and its association with well-known geriatric syndromes: is treatment beneficial? , 2013, Rejuvenation research.

[10]  C. Stournaras,et al.  Differential effects of dehydroepiandrosterone and testosterone in prostate and colon cancer cell apoptosis: the role of nerve growth factor (NGF) receptors. , 2013, Endocrinology.

[11]  Lei Zhu,et al.  Acetylcholine Acts on Androgen Receptor to Promote the Migration and Invasion but Inhibit the Apoptosis of Human Hepatocarcinoma , 2013, PloS one.

[12]  Sheng Lin,et al.  Thyroid hormone regulation of miR-21 enhances migration and invasion of hepatoma. , 2013, Cancer research.

[13]  K. Fukunaga,et al.  Stimulation of the Sigma-1 Receptor by DHEA Enhances Synaptic Efficacy and Neurogenesis in the Hippocampal Dentate Gyrus of Olfactory Bulbectomized Mice , 2013, PloS one.

[14]  Yasuhiro Nakamura,et al.  Liquid chromatography-tandem mass spectrometry analysis of human adrenal vein 19-carbon steroids before and after ACTH stimulation. , 2013, The Journal of clinical endocrinology and metabolism.

[15]  D. Sisci,et al.  G Protein-coupled Estrogen Receptor Mediates the Up-regulation of Fatty Acid Synthase Induced by 17β-Estradiol in Cancer Cells and Cancer-associated Fibroblasts* , 2012, The Journal of Biological Chemistry.

[16]  M. Tevfik Dorak,et al.  Gender Differences in Cancer Susceptibility: An Inadequately Addressed Issue , 2012, Front. Gene..

[17]  Yuanyuan Wu,et al.  Estrogen Represses Hepatocellular Carcinoma (HCC) Growth via Inhibiting Alternative Activation of Tumor-associated Macrophages (TAMs)* , 2012, The Journal of Biological Chemistry.

[18]  George Notas,et al.  Interplay of estrogen receptors and GPR30 for the regulation of early membrane initiated transcriptional effects: A pharmacological approach , 2012, Steroids.

[19]  P. Linsley,et al.  Disease-linked microRNA-21 exhibits drastically reduced mRNA binding and silencing activity in healthy mouse liver. , 2012, RNA.

[20]  T. Tamaki,et al.  Estrogen Regulates Hepcidin Expression via GPR30-BMP6-Dependent Signaling in Hepatocytes , 2012, PloS one.

[21]  P. Jansen,et al.  Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma. , 2012, Journal of hepatology.

[22]  Zhiming Wang,et al.  miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma. , 2012, Oncology reports.

[23]  P. Thomas,et al.  Minireview: G protein-coupled estrogen receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiology. , 2012, Endocrinology.

[24]  O. Hennebert,et al.  The DHEA metabolite 7β-hydroxy-epiandrosterone exerts anti-estrogenic effects on breast cancer cell lines , 2012, Steroids.

[25]  S. Flament,et al.  Estrogens promote proliferation of the seminoma-like TCam-2 cell line through a GPER-dependent ERα36 induction , 2012, Molecular and Cellular Endocrinology.

[26]  R. Girgert,et al.  Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy , 2012, Breast Cancer Research and Treatment.

[27]  Zhaoyu Li,et al.  Foxa1 and Foxa2 Are Essential for Sexual Dimorphism in Liver Cancer , 2012, Cell.

[28]  B. Boyan,et al.  Membrane Estrogen Signaling Enhances Tumorigenesis and Metastatic Potential of Breast Cancer Cells via Estrogen Receptor-α36 (ERα36)* , 2012, The Journal of Biological Chemistry.

[29]  Richa Tiwary,et al.  Targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer , 2011, Breast Cancer Research.

[30]  A. Traish,et al.  Dehydroepiandrosterone (DHEA)--a precursor steroid or an active hormone in human physiology. , 2011, The journal of sexual medicine.

[31]  Laura Beretta,et al.  Circulating MicroRNAs in Patients with Chronic Hepatitis C and Non-Alcoholic Fatty Liver Disease , 2011, PloS one.

[32]  E. Prossnitz,et al.  The G-protein-coupled estrogen receptor GPER in health and disease , 2011, Nature Reviews Endocrinology.

[33]  Xuehao Wang,et al.  miR-22 Promotes HBV-Related Hepatocellular Carcinoma Development in Males , 2011, Clinical Cancer Research.

[34]  Heike Allgayer,et al.  Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer. , 2011, Bioscience reports.

[35]  G. Carruba,et al.  Expression of wild-type and variant estrogen receptor alpha in liver carcinogenesis and tumor progression. , 2011, Omics : a journal of integrative biology.

[36]  Dalei Wu,et al.  FRET analysis of protein tyrosine kinase c-Src activation mediated via aryl hydrocarbon receptor. , 2011, Biochimica et biophysica acta.

[37]  M. Albitar,et al.  Circulating MicroRNAs as Biomarkers for Hepatocellular Carcinoma , 2011, Journal of clinical gastroenterology.

[38]  G. Goodall,et al.  Induction of miR-21 by Retinoic Acid in Estrogen Receptor-positive Breast Carcinoma Cells , 2010, The Journal of Biological Chemistry.

[39]  M. Maggiolini,et al.  Nuclear alternate estrogen receptor GPR30 mediates 17beta-estradiol-induced gene expression and migration in breast cancer-associated fibroblasts. , 2010, Cancer research.

[40]  Y. Hung,et al.  Androgen Receptor Promotes Hepatitis B Virus–Induced Hepatocarcinogenesis Through Modulation of Hepatitis B Virus RNA Transcription , 2010, Science Translational Medicine.

[41]  Terence P. Speed,et al.  Estrogen Receptor β Binds to and Regulates Three Distinct Classes of Target Genes* , 2010, The Journal of Biological Chemistry.

[42]  Yan Xie,et al.  Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling. , 2010, Molecular endocrinology.

[43]  S. Ho,et al.  Activation of GPR30 inhibits growth of prostate cancer cells via sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G2 cell-cycle arrest , 2010, Cell Death and Differentiation.

[44]  P. Leung,et al.  Gonadotropin-releasing hormone-mediated phosphorylation of estrogen receptor-alpha contributes to fosB expression in mouse gonadotrophs. , 2009, Endocrinology.

[45]  E. Prossnitz,et al.  Mechanisms of estrogen signaling and gene expression via GPR30 , 2009, Molecular and Cellular Endocrinology.

[46]  Tudor I. Oprea,et al.  In vivo Effects of a GPR30 Antagonist , 2009, Nature chemical biology.

[47]  Megan Coleman,et al.  Estrogen receptor‐alpha (ER‐α) suppresses expression of its variant ER‐α36 , 2009, FEBS letters.

[48]  N. Colburn,et al.  MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene , 2008, Oncogene.

[49]  J. Wen,et al.  Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells. , 2008, Molecular endocrinology.

[50]  Sun Hee Jin,et al.  Methyl-β-cyclodextrin, a specific cholesterol-binding agent, inhibits melanogenesis in human melanocytes through activation of ERK , 2008, Archives of Dermatological Research.

[51]  Shuji Fujita,et al.  miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism. , 2008, Journal of molecular biology.

[52]  C. Klinge,et al.  Estradiol stimulates transcription of nuclear respiratory factor-1 and increases mitochondrial biogenesis. , 2008, Molecular endocrinology.

[53]  John H. White,et al.  Mechanisms of primary and secondary estrogen target gene regulation in breast cancer cells , 2007, Nucleic acids research.

[54]  K. Ghoshal,et al.  MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. , 2007, Gastroenterology.

[55]  C. Klinge,et al.  Decreased chicken ovalbumin upstream promoter transcription factor II expression in tamoxifen-resistant breast cancer cells. , 2006, Cancer research.

[56]  H. Zhang,et al.  Involvement of programmed cell death 4 in transforming growth factor-β1-induced apoptosis in human hepatocellular carcinoma , 2006, Oncogene.

[57]  T. Simoncini,et al.  Estrogen Receptor α Interacts with Gα13 to Drive Actin Remodeling and Endothelial Cell Migration via the RhoA/Rho Kinase/Moesin Pathway , 2006 .

[58]  Tudor I. Oprea,et al.  Virtual and biomolecular screening converge on a selective agonist for GPR30 , 2006, Nature chemical biology.

[59]  N. Avlonitis,et al.  G protein‐associated, specific membrane binding sites mediate the neuroprotective effect of dehydroepiandrosterone , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[60]  R. Prough,et al.  The Biological Actions of Dehydroepiandrosterone Involves Multiple Receptors , 2006, Drug metabolism reviews.

[61]  D. Mayer,et al.  Impact of dehydroepiandrosterone on hepatocarcinogenesis in the rat (Review). , 2004, International journal of oncology.

[62]  B. P. Ceresa,et al.  Continual Expression of Rab5(Q79L) Causes a Ligand‐Independent EGFR Internalization and Diminishes EGFR Activity , 2004, Traffic.

[63]  Dongmin Liu,et al.  Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: evidence for a cell surface receptor , 2004, Steroids.

[64]  J. Marks,et al.  Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis. , 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[65]  R. V. van Etten,et al.  Modulation of hepatic acute phase gene expression by epidermal growth factor and src protein tyrosine kinases in murine and human hepatic cells , 1999, Hepatology.

[66]  B. Deurs,et al.  Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles. , 1999, Molecular biology of the cell.

[67]  D. Lannigan,et al.  Estradiol-induced Phosphorylation of Serine 118 in the Estrogen Receptor Is Independent of p42/p44 Mitogen-activated Protein Kinase* , 1998, The Journal of Biological Chemistry.

[68]  J. Goméz,et al.  Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. , 1997, The Journal of clinical endocrinology and metabolism.

[69]  H. Olivier,et al.  The DHEA metabolite 7β-hydroxy-epiandrosterone exerts anti-estrogenic effects on breast cancer cell lines. , 2012, Steroids.

[70]  H. Ho,et al.  Dehydroepiandrosterone induces growth arrest of hepatoma cells via alteration of mitochondrial gene expression and function. , 2008, International journal of oncology.

[71]  B. Wilson,et al.  Androgen induces adaptation to oxidative stress in prostate cancer: implications for treatment with radiation therapy. , 2007, Neoplasia.

[72]  D. Woodfield Hepatocellular carcinoma. , 1986, The New Zealand medical journal.